BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15523617)

  • 1. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.
    Khosrotehrani K; Bastuji-Garin S; Riccardi VM; Birch P; Friedman JM; Wolkenstein P
    Am J Med Genet A; 2005 Jan; 132A(1):49-53. PubMed ID: 15523617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients.
    Khosrotehrani K; Bastuji-Garin S; Zeller J; Revuz J; Wolkenstein P
    Arch Dermatol; 2003 Feb; 139(2):187-91. PubMed ID: 12588224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
    Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
    Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.
    Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
    Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study.
    Sbidian E; Hadj-Rabia S; Riccardi VM; Valeyrie-Allanore LL; Barbarot S; Chosidow O; Ferkal S; Rodriguez D; Wolkenstein P; Bastuji-Garin S
    Orphanet J Rare Dis; 2012 Sep; 7():62. PubMed ID: 22943186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
    Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
    PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C2 neurofibromas in neurofibromatosis type 1: genetic and imaging characteristics.
    Waqar M; Huson S; Evans DG; Ealing J; Karabatsou K; George KJ; Soh C
    J Neurosurg Spine; 2018 Oct; 30(1):126-132. PubMed ID: 30485203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
    Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
    Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas: a study of 226 cases.
    Ball NJ; Kho GT
    J Cutan Pathol; 2005 Sep; 32(8):523-32. PubMed ID: 16115049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.
    Prada CE; Rangwala FA; Martin LJ; Lovell AM; Saal HM; Schorry EK; Hopkin RJ
    J Pediatr; 2012 Mar; 160(3):461-7. PubMed ID: 21996156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    Cancer Genet Cytogenet; 2002 Jul; 136(2):113-20. PubMed ID: 12237234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
    Odebode TO; Afolayan EA; Adigun IA; Daramola OO
    Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
    Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
    Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
    Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
    Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study.
    Sbidian E; Bastuji-Garin S; Valeyrie-Allanore L; Ferkal S; Lefaucheur JP; Drouet A; Brugière P; Vialette C; Combemale P; Barbarot S; Wolkenstein P;
    Orphanet J Rare Dis; 2011 Jul; 6():51. PubMed ID: 21752287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.